Our Technology Partn3Ring webinar series showcases technologies with 3Rs potential to the wider scientific community to identify new partners for further development, qualification and use. Webinars consist of short pitches outlining the 3Rs technologies and unique opportunities for collaboration.
The webinar is open to researchers, clinicians, pharmaceutical and industry professionals. Audience members will be able to ask questions to the speakers and learn about how to get involved with each opportunity.
Present a collaboration opportunity
You should consider presenting at a future Technology Partn3Ring webinar if your technology, tool or service has the potential to deliver 3Rs benefits and:
You are seeking collaborators to support the further development required to achieve this and maximise the scientific, commercial and animal welfare benefits of your approach.
or
- You are seeking users of your technology to realise the 3Rs impacts of your approach.
Presentations are welcome from researchers and technology developers from across the life science sector, including academia and SMEs.
If you are interested in presenting please complete the brief Technology Partn3Ring presentation form below. Potential speakers should summarise the need for collaboration, including a short description of the technology, its potential applications and 3Rs impacts and the type of expertise that is sought. Once the completed form has been submitted we will be in touch to discuss presentation opportunities.
Complete the Technology Partn3Ring presentation form
Showcased technologies
The recorded pitches from previous webinars will be available within one week of the session and will be accessible for 12 months.
Cardiovascular Technology Partn3Ring: Thursday 27 February 2025
Researchers can also engage with our Cardiovascular Network that supports scientists from across sectors to establish collaborations and catalyses the uptake of 3Rs technologies.
Professor Manasi Nandi, Kings College London
Pitch title: Adding a new dimension to vital sign data to detect drug, gene or disease effects: SPAR.
Collaboration opportunity: Any academic or industry scientists who collect continuous continuous cyclic data. Typically those sampling cardiovascular or respiratory waveforms to understand the effects of gene/drug/model intervention on cardiovascular and respiratory physiology.
Professor Helen Maddock, InoCardia
Pitch title: Functional human heart tissue (native & engineered) model.
Collaboration opportunity: Pharmaceutical companies, CROs, Stem Cell companies/developers and academics interested in collaboration or partnering.
Professor Beata Wojciak-Stothard, Imperial College London
Pitch title: Capturing complexity: organ-on-a-chip models of vascular dysfunction in lung disease.
Collaboration opportunity: Input from the Pharmaceutical industry on how to optimise the model and what measurable outputs are important for its further development. The team would like to test the system for drug screening and toxicology studies.